This finding aligns with the “metabolic–neurodegenerative axis” hypothesis, which suggests that chronic hyperglycemia and insulin resistance may undermine potential dietary benefits by promoting amyloid deposition, damaging the blood–brain barrier, and disrupting insulin signaling within the brain [65]. This evidence concerns the gene INS and Hyperglycemia.